In the current study, we demonstrated the role of FSCN1 in the progression of HNSCC by analyzing serum levels of FSCN1 and estimating the number of cells expressing FSCN1 in the tumor and the number of CTCs containing this protein. The gene discussed is FSCN1; the disease is neoplasm.